• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
National Health Insurance Databases in Indonesia, Vietnam and the Philippines.印度尼西亚、越南和菲律宾的国家健康保险数据库。
Pharmacoecon Open. 2019 Dec;3(4):517-526. doi: 10.1007/s41669-019-0127-2.
2
Appraisal of universal health insurance and maternal health services utilization: pre- and post-context of the Jaminan Kesehatan Nasional implementation in Indonesia.全民健康保险与孕产妇卫生服务利用评估:印度尼西亚实施国家健康保险计划前后的情况。
Front Public Health. 2024 Mar 14;12:1301421. doi: 10.3389/fpubh.2024.1301421. eCollection 2024.
3
Utilization patterns of healthcare facility and estimated expenditure of PLHIV care under the Indonesian National Health Insurance Scheme in 2018.2018 年印度尼西亚国家医疗保险计划下艾滋病毒感染者保健设施利用模式和保健支出估计数。
BMC Health Serv Res. 2022 Jan 22;22(1):97. doi: 10.1186/s12913-021-07434-9.
4
The influence of Jaminan Kesehatan Nasional (JKN) on the cost of delivery services in Indonesia.印度尼西亚全民健康保险(JKN)对分娩服务成本的影响。
PLoS One. 2020 Jul 2;15(7):e0235176. doi: 10.1371/journal.pone.0235176. eCollection 2020.
5
How Jaminan Kesehatan Nasional (JKN) coverage influences out-of-pocket (OOP) payments by vulnerable populations in Indonesia.印度尼西亚的国家健康保险(JKN)覆盖范围如何影响弱势群体的自付费用。
PLOS Glob Public Health. 2022 Jul 7;2(7):e0000203. doi: 10.1371/journal.pgph.0000203. eCollection 2022.
6
Indonesia: On the Way to Universal Health Care.印度尼西亚:迈向全民医疗保健之路。
Health Syst Reform. 2015 Feb 17;1(2):91-97. doi: 10.1080/23288604.2015.1020642.
7
Availability and Accessibility of Primary Care for the Remote, Rural, and Poor Population of Indonesia.印度尼西亚偏远、农村和贫困人口的初级保健的可及性和可及性。
Front Public Health. 2021 Sep 21;9:721886. doi: 10.3389/fpubh.2021.721886. eCollection 2021.
8
Association of SHI coverage and level of healthcare utilization and costs in the Philippines: a 10-year pooled analysis.菲律宾 SHI 覆盖范围和医疗利用程度及成本的关联:一项为期 10 年的汇总分析。
J Public Health (Oxf). 2020 Nov 23;42(4):e496-e505. doi: 10.1093/pubmed/fdz142.
9
Health services provision and decision to buy Jaminan Kesehatan Nasional (JKN) in Indonesia.印度尼西亚的医疗服务提供与购买国民健康保险(JKN)的决策。
Health Policy Open. 2021 Jul 31;2:100050. doi: 10.1016/j.hpopen.2021.100050. eCollection 2021 Dec.
10
Implementation Research to Strengthen Health Care Financing Reforms Toward Universal Health Coverage in Indonesia: A Mixed-Methods Approach to Real-World Monitoring.实施研究以加强印度尼西亚全民健康覆盖的医疗保健融资改革:现实世界监测的混合方法。
Glob Health Sci Pract. 2018 Dec 27;6(4):747-753. doi: 10.9745/GHSP-D-18-00328.

引用本文的文献

1
The burden of intracerebral hemorrhage attributable to ambient particulate matter pollution in five Asian countries: a 32-year comparative analysis.五个亚洲国家中环境颗粒物污染所致脑出血负担:一项32年的比较分析。
BMC Public Health. 2025 Jul 15;25(1):2467. doi: 10.1186/s12889-025-23531-4.
2
Data for public health analysis in the ASEAN countries: a scoping review protocol.东盟国家公共卫生分析数据:一项范围综述方案
BMJ Public Health. 2025 Jun 18;3(1):e002049. doi: 10.1136/bmjph-2024-002049. eCollection 2025.
3
A framework for improved collaboration on HTA in the Asia-Pacific region: a role for HTAsiaLink.亚太地区卫生技术评估合作的改进框架:HTAsiaLink 的作用。
Int J Technol Assess Health Care. 2024 Nov 4;40(1):e43. doi: 10.1017/S0266462324000588.
4
Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries.弥合现实世界的数据差距:连接10个亚洲国家的数据点。
JMIR Med Inform. 2024 Aug 15;12:e58548. doi: 10.2196/58548.
5
Claims data from health insurance programmes in sub-Saharan Africa: an untapped resource to promote Universal Health Coverage.撒哈拉以南非洲地区医疗保险计划的理赔数据:促进全民健康覆盖的未开发资源。
BMJ Glob Health. 2024 Jul 10;9(7):e015310. doi: 10.1136/bmjgh-2024-015310.
6
The impact of multimorbidity among adults with cardiovascular diseases on healthcare costs in Indonesia: a multilevel analysis.成年人心血管疾病合并症对印度尼西亚医疗保健费用的影响:多层次分析。
BMC Public Health. 2024 Mar 15;24(1):816. doi: 10.1186/s12889-024-18301-7.
7
Effects of the COVID-19 pandemic on cardiovascular disease financing in Indonesia (JKN claims data analysis 2019-2020).新冠疫情对印度尼西亚心血管疾病融资的影响(2019-2020 年 JKN 理赔数据分析)。
Front Public Health. 2023 Mar 31;11:1148394. doi: 10.3389/fpubh.2023.1148394. eCollection 2023.
8
Purchasing for high-quality care using National Health Insurance: evidence from Zambia.利用国家医疗保险购买高质量的医疗服务:来自赞比亚的证据。
Health Policy Plan. 2023 Jun 16;38(6):681-688. doi: 10.1093/heapol/czad022.
9
Outpatient antibiotic prescribing for acute respiratory infections in Vietnamese primary care settings by the WHO AWaRe (Access, Watch and Reserve) classification: An analysis using routinely collected electronic prescription data.世界卫生组织基本药物目录(获取、观察和储备)分类下越南基层医疗环境中急性呼吸道感染的门诊抗生素处方:一项使用常规收集的电子处方数据的分析
Lancet Reg Health West Pac. 2022 Oct 11;30:100611. doi: 10.1016/j.lanwpc.2022.100611. eCollection 2023 Jan.
10
Factors Affecting Payment Compliance of the Indonesia National Health Insurance Participants.影响印度尼西亚国家医疗保险参与者支付合规性的因素
Risk Manag Healthc Policy. 2022 Feb 22;15:277-288. doi: 10.2147/RMHP.S347823. eCollection 2022.

本文引用的文献

1
How Could Private Healthcare Better Contribute to Healthcare Coverage in Vietnam?私人医疗如何能更好地为越南的医疗保健覆盖做出贡献?
Int J Health Policy Manag. 2017 Jun 1;6(6):305-308. doi: 10.15171/ijhpm.2017.05.
2
Economic Burden of Community-Acquired Pneumonia Among Pediatric Patients (Aged 3 Months to < 19 Years) in the Philippines.菲律宾3个月至不满19岁儿童社区获得性肺炎的经济负担
Value Health Reg Issues. 2017 May;12:115-122. doi: 10.1016/j.vhri.2017.04.003. Epub 2017 May 31.
3
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.法国的国家医疗保健系统拥有SNIIRAM和EGB数据库:药物流行病学的强大工具。
Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):954-962. doi: 10.1002/pds.4233. Epub 2017 May 24.
4
Epidemiologic burden of hospitalisation for congestive heart failure among adults aged ≥19 years in the Philippines.菲律宾19岁及以上成年人因充血性心力衰竭住院的流行病学负担。
Heart Asia. 2017 Mar 27;9(1):76-80. doi: 10.1136/heartasia-2016-010862. eCollection 2017.
5
Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data.实现韩国健康保险审查与评估(HIRA)数据作为健康研究资源的价值潜力:HIRA数据的优势、局限性、应用及最佳使用策略
J Korean Med Sci. 2017 May;32(5):718-728. doi: 10.3346/jkms.2017.32.5.718.
6
A review of accessibility of administrative healthcare databases in the Asia-Pacific region.亚太地区行政医疗保健数据库的可及性综述。
J Mark Access Health Policy. 2015 Jul 20;3. doi: 10.3402/jmahp.v3.28076. eCollection 2015.
7
Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database.全国人口科学:来自台湾全民健康保险研究数据库的经验教训。
JAMA Intern Med. 2015 Sep;175(9):1527-9. doi: 10.1001/jamainternmed.2015.3540.
8
Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach.简短报告:亚太地区的数据库:分布式网络方法的潜力
Epidemiology. 2015 Nov;26(6):815-20. doi: 10.1097/EDE.0000000000000325.
9
Progress toward universal health coverage in ASEAN.东盟在全民健康覆盖方面取得的进展。
Glob Health Action. 2014 Dec 3;7:25856. doi: 10.3402/gha.v7.25856. eCollection 2014.
10
A systematic review of barriers to data sharing in public health.一项关于公共卫生领域数据共享障碍的系统综述。
BMC Public Health. 2014 Nov 5;14:1144. doi: 10.1186/1471-2458-14-1144.

印度尼西亚、越南和菲律宾的国家健康保险数据库。

National Health Insurance Databases in Indonesia, Vietnam and the Philippines.

作者信息

Ng Junice Yi Siu, Ramadani Royasia Viki, Hendrawan Donni, Duc Duong Tuan, Kiet Pham Huy Tuan

机构信息

Real-World Insights, IQVIA Asia-Pacific, 79 Anson Road, #19-01, Singapore, 079906, Singapore.

Center for Health Economics and Policy Studies, Faculty of Public Health, Universitas Indonesia, Beji, Kota Depok, Jawa Barat, Indonesia.

出版信息

Pharmacoecon Open. 2019 Dec;3(4):517-526. doi: 10.1007/s41669-019-0127-2.

DOI:10.1007/s41669-019-0127-2
PMID:30859490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6861401/
Abstract

BACKGROUND

Social health insurance administrative databases were established in Indonesia, Vietnam and the Philippines in 2014, 2017 and 2012, respectively; however, these databases have been scarcely used for research, if at all. This study explored the feasibility and accessibility of using these databases for scientific research, highlighting challenges and barriers in their use.

METHODOLOGY

The databases included in this evaluation comprised the Jaminan Kesehatan Nasional (JKN) from Indonesia, Vietnam Health Insurance Scheme (VHIS) from Vietnam and PhilHealth from the Philippines. These databases were qualitatively assessed based on the data capture, potential linkage to other databases or registries, data access and extraction, privacy and security, and quality and validation procedures.

RESULTS

All databases contain population-based cohort data on the medical costs of reimbursed medical conditions, identified using International Classification of Diseases, Tenth Revision (ICD-10) codes. Linkage to other national databases, ensuring protection of patient privacy data, would improve their usability. Duration to database access and data extraction varies from country to country. The main limitations of all databases include the short span of data records, and the unknown degree of internal validity. Both JKN and PhilHealth databases capture bundled claims, inherently excluding information on prescriptions and out-of-pocket expenditure. Due to the recent establishment of the VHIS database, it may not be suitable for studies that intend to explore trends.

CONCLUSION

The JKN, VHIS and PhilHealth databases offer population-based, financial, utilization, and demographic data, which could provide valuable epidemiological and pharmacoeconomic insights if the findings are interpreted within the limitations of each database.

摘要

背景

印度尼西亚、越南和菲律宾分别于2014年、2017年和2012年建立了社会医疗保险行政数据库;然而,这些数据库即便有被用于研究,也是极少的。本研究探讨了使用这些数据库进行科学研究的可行性和可及性,突出了使用过程中的挑战和障碍。

方法

本评估纳入的数据库包括印度尼西亚的国民健康保险(JKN)、越南的越南健康保险计划(VHIS)和菲律宾的菲律宾健康保险公司(PhilHealth)。基于数据采集、与其他数据库或登记处的潜在关联、数据访问与提取、隐私与安全以及质量与验证程序,对这些数据库进行了定性评估。

结果

所有数据库都包含基于人群的队列数据,涉及使用国际疾病分类第十版(ICD-10)编码确定的已报销医疗状况的医疗费用。与其他国家数据库建立关联,确保患者隐私数据得到保护,将提高其可用性。不同国家获取数据库和提取数据的时间各不相同。所有数据库的主要局限性包括数据记录跨度短,以及内部效度未知。JKN和PhilHealth数据库均记录捆绑式索赔,本质上不包括处方和自付费用信息。由于VHIS数据库建立时间较短,可能不适合用于探索趋势的研究。

结论

JKN、VHIS和PhilHealth数据库提供了基于人群的财务、使用情况和人口统计数据,如果在每个数据库的局限性内解读研究结果,这些数据可以提供有价值的流行病学和药物经济学见解。